Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiac Electrophysiology
What sheath(s) is preferred for crossing a bioprosthetic aortic valve during VT ablation?
Related Questions
How soon after initiating oral anticoagulation therapy for atrial fibrillation can it be interrupted for surgery or procedures?
What is your approach to anticoagulation in cirrhotic patients with platelet count loss than 50 in the setting of atrial fibrillation and elevated CHADSVASC?
How would you approach the management of a patient who develops an accelerated junctional rhythm who exhibits no symptoms and has no prior history of cardiac issues, aside from consulting a cardiologist?
How do you determine the appropriate timing and criteria for safely reintroducing AV-nodal blocking agents after initial stabilization and improvement of renal function and hyperkalemia in patients with BRASH syndrome?
Would you consider a secondary prevention ICD in a patient who had a cardiac arrest deemed attributable to a spontaneous coronary artery dissection (SCAD), with no intervention performed?
What is your approach to management of chronic GI bleeding from AVM's in elderly patient on DOAC for atrial fibrillation?
How do you approach agitation management, especially the use of neuroleptics in hospitalized patients with a prolonged QTc?
Does the presence of diastolic dysfunction guide subsequent pharmacological, pacing and ablative therapies for atrial fibrillation?
Would you make any dialysis prescription modifications for an ESKD patient who develops tachycardia during a hemodialysis session?
If a patient has potential arrhythmic-sounding syncope and a noninducible type 2 or 3 Brugada ECG pattern, have we excluded Brugada syndrome as the etiology for their syncope?
